1-3 of 3
Priscila Keiko Matsumoto Martin
Close
Sort by
Journal Articles

Impact of Ethnic Origin on CRISPR/Cas Off-Target Prediction for Guide RNAs Used in Gene Therapy for Sickle Cell Disease and Other Genetic Diseases

Davi Coe Coe Torres, Karina Griesi-Oliveira, Karina Tozatto-Maio, Andrea Laurato Sertié, Mariana Morato Marques, Priscila Keiko Matsumoto Martin, Mariana Benicio, Barbara Ferri Moraschi, Lucas Assis Pereira, Luiz Vicente Rizzo, Ricardo Weinlich
Journal: Blood
Blood (2021) 138 (Supplement 1): 1857.
https://doi.org/10.1182/blood-2021-153088
Published: 2021
Journal Articles

Knockdown of HNF4A Gene Increases Fetal Hemoglobin Synthesis in Hudep-2

Ingrid Grazielle Sousa, BSc, MSc, Priscila Keiko Matsumoto Martin, PhD, Dulcinéia Martins de Albuquerque, BSc, PhD, Carolina Lanaro, BSc, PhD, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, Fernando Ferreira Costa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 968.
https://doi.org/10.1182/blood-2019-130920
Published: 2019
Journal Articles

A Single -195 C < G HBG1 Promoter Mediated By CRISPR/Cas9 Genome Editing Induces Fetal Hemoglobin Synthesis in Hudep-2

Priscila Keiko Matsumoto Martin, PhD, Dulcinéia Martins de Albuquerque, PhD, Carolina Lanaro, PhD, Ryo Kurita, PhD, Yukio Nakamura, MD PhD, Fernando F. Costa, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3481.
https://doi.org/10.1182/blood-2018-99-118534
Published: 2018